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Studies on structure and function of polysaccharides in biological systems classically involve
sequence and compositional analyses, anomeric conﬁguration, type of glycosidic linkage,
and presence of substituents. Recent studies, however, indicates that other structural
parameters, so far little explored, can directly inﬂuence the biological activity of microbial
polysaccharides. Among these parameters, we highlight themolecular dimensions of Cryp-
tococcus neoformans polysaccharides, which appear to be inversely correlated with their
immunobiological activity. These recent observations raise new concepts about the struc-
ture and function of polysaccharides, which stimulates the design of new experimental
approaches and suggests previously unknown applications.
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Polysaccharides are cellular structural components found in the
three domains of life. In microorganisms, several studies have
shown that polysaccharides play crucial roles in the architecture
of the cell envelope (Roberts, 1996; Nimrichter et al., 2005). In
both prokaryotic and eukaryoticmicrobial pathogens,polysaccha-
rides are major cell wall components (Roberts, 1996; Nimrichter
et al., 2005). This surface distribution is in agreement with the fact
that polysaccharide molecules directly inﬂuence host–pathogen
interactions (Moxon and Kroll, 1990; Smith, 1990; Levitz, 2004;
Zaragoza et al., 2009).
Polysaccharides consist of polymeric structures composed of
at least ten monosaccharides sequentially connected by glycosidic
bonds (Bertozzi and Rabuka, 2009; Mulloy et al., 2009; Stan-
ley and Cummings, 2009). These structures may be linear or
branched, a characteristic that is observedwhen amonosaccharide
constituent of a polysaccharide is involved in more than two gly-
cosidic bonds. Polysaccharides can be classiﬁed as homopolymers,
a term used to indicate a polymer composed of identical mono-
saccharides, or heteropolymers, a term used for classiﬁcation of
polysaccharides composed of two or more types of monosaccha-
rides. Classic approaches for the determination of polysaccharide
structure include chromatographic methods in association with
spectrometric and spectroscopic techniques. These approaches
allow determination of sequence and composition, anomeric con-
ﬁguration, type of glycosidic linkage, and presence of substituents
(Mulloy et al., 2009).
Capsular polysaccharides were amongst the earliest microbial
virulence determinants described in the literature, as demon-
strated in the classic Grifﬁth’s experiment [review in (Smith,
1990)]. This pioneering study established a direct relationship
between the presence of polysaccharide capsules in bacterial
pathogens and protection against host defenses. Subsequently,
over several decades, the association between microbial virulence
and capsular polysaccharides has been consolidated (Moxon and
Kroll, 1990; Monari et al., 2006; Vecchiarelli, 2007; Zaragoza et al.,
2009), although it is clear that in some cases, these structures work
in favor of the host (Mazmanian and Kasper, 2006; Pletz et al.,
2008;Kumar et al., 2009). Consequently,microbial polysaccharides
may work in favor of the pathogen or induce immune responses
that promote infection control, depending on their chemistry
and/or structural aspects.
Classically, polysaccharide antigens have been considered poor
inducers of cellular immunity. In fact, polysaccharide molecules
are considered T-cell independent antigens that are more efﬁcient
activators of antibody production than of cell-mediated immune
responses (Weintraub, 2003). In the last decade, however, a num-
ber of studies have demonstrated the role of polysaccharides in
the activation of innate immunological mechanisms [reviewed in
(Raetz and Whitﬁeld, 2002; Kumar et al., 2009)]. In addition, the
conjugation of polysaccharides to protein structures can generate
hybrid molecules of increased immunogenicity. In fact, vaccines
containing polysaccharides against several prokaryotic pathogens
have proven successful and are commercially available (Pichichero,
2005; Pletz et al., 2008).
Polysaccharides are essential for pathogenic mechanisms and
for the immune response during fungal infections (Roeder et al.,
2004). Unlike mammalian cells, fungi have a cell wall, a complex
compartment mainly composed of polysaccharides (Nimrichter
et al., 2005). Glucans, chitin, and mannans (polymers consisting
of repeating units of, respectively, glucose, N -acetylglucosamine,
and mannose) are particularly abundant in the fungal cell
wall. Depending on their structural particularities, cell wall
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polysaccharides function as regulators of virulence or activators of
innate immunity (Roeder et al., 2004; Zaragoza et al., 2009). Well
characterized immunoactive polysaccharides produced by fungi
include α- and β-glucans (Brown et al., 2003; Hohl et al., 2005;
Bittencourt et al., 2006; Rappleye et al., 2007; Wheeler et al., 2008;
van de Veerdonk et al., 2009; Chai et al., 2011) and complex man-
nans (Leitao et al., 2003; Cambi et al., 2008; van deVeerdonk et al.,
2009). Candida albicans, Aspergillus fumigatus, Histoplasma cap-
sulatum, Cryptococcus neoformans, and C. gattii are examples of
fungal pathogens in which the immune functions of polysaccha-
rides are known in great detail (Monari et al., 2006; Rappleye et al.,
2007; Cambi et al., 2008; Chai et al., 2011).
Cryptococcus neoformans and C. gattii are the etiologic agents
of cryptococcosis, a disease that presumably begins in the lung. In
immunocompromised individuals,C. neoformans can disseminate
to the central nervous system and other organs (Bicanic and Har-
rison, 2004). C. gattii, on the other hand, can cause disseminated
disease in immunocompetent individuals (Byrnes et al., 2011).
It is estimated that about one million new cases of cryptococco-
sis occur annually, with mortality rates that can reach 60% (Park
et al., 2009). In Brazil, cryptococcosis is the fungal disease with
highest mortality rates among HIV-positive individuals (Prado
et al., 2009). C. neoformans and C. gattii have polysaccharide cap-
sules surrounding the cell body. Bacterial capsules are common
in bacterial pathogens, but relatively rare and still poorly deﬁned
among eukaryotic organisms.
In C. neoformans and C. gattii, the capsule is mainly composed
of the polysaccharides glucuronoxylomannan (GXM) and galac-
toxylomannan (GalXM; Zaragoza et al., 2009; Rodrigues et al.,
2011). An alteration in the GalXM nomenclature to glucuronoxy-
lomannogalactan (GXMGal) has been recently proposed based
on structural aspects and monosaccharide composition (Heiss
et al., 2009). The principal capsular polysaccharide component
in both species is GXM, which consists of a polymer composed
of an α1,3 linked mannosyl backbone with β1,2 and β1,4 xylo-
syl and glucuronyl substitutions (for details, see Zaragoza et al.,
2009). Structural variation resulting from differences in composi-
tion, substitution,and conformation results in different serological
properties. These GXM properties divide C. neoformans strains
into fourmain serotypes:A andD,produced byC. neoformans, and
B and C, produced by C. gattii [review in (Zaragoza et al., 2009;
Rodrigues et al., 2011)]. Hybrid serotypes have been also charac-
terized in different regions (Xu et al., 2002). GXM is believed to
be synthesized intracellularly, possibly in close association to lipid
structures (Rodrigues et al., 2007; Oliveira et al., 2009). For con-
struction of the capsule, yeast cells secrete polysaccharides into the
extracellular environment by mechanisms that involve the release
of vesicles for subsequent polysaccharide incorporation into the
cell surface, for distal capsular enlargement (Zaragoza et al., 2006;
Rodrigues et al., 2007).
It is assumed that synthesis of GXM and its release to the
extracellular space are crucial for the immunopathogenesis of
cryptococcosis. In general, GXM is deleterious to the immune
system (Monari et al., 2006), although several reports indicate
that this polysaccharide is a potent activator of the comple-
ment system and of the innate immunity [review in (Zaragoza
et al., 2009)]. Fractions of extracellular GXM released into the
medium were recently shown to differ in structure and func-
tion from capsular polysaccharide extracts (Frases et al., 2008).
These observations suggested thatC. neoformans and C. gattii cells
produce highly diverse populations of GXM that show structural
peculiarities with possible implications on their biological roles.
In fact, various studies have established that the production of
polysaccharides by C. neoformans includes GXM molecules with
highly variable dimensions, which interact through several mech-
anisms to form the capsular network (Nimrichter et al., 2007;
Frases et al., 2009). These studies raised an important question:
do polysaccharide samples of identical composition but vari-
able size and degree of polymerization present distinct biological
functions?
The hypothesis raised above is supported by observations
that have recently become available in the literature. Chitin, a
linear polysaccharide found in fungi, crustaceous, insects, and
parasites, is a water insoluble polymer composed of units of
β1,4-linked N -acetylglucosamine. As described by Da Silva et al.
(2008, 2009), fractions of chitin with high molecular dimen-
sions are immunologically inert. Polysaccharide samples with
reduced dimensions, however, were associated with the effective
stimulation of innate immunity and production of pro- and anti-
inﬂammatory cytokines. These observations have established a
clear precedent in the literature indicating that polysaccharide
samples of identical composition but with varying dimensions
may have different functions.
The observation described above and the fact that capsular
structures of Cryptococcus species are composed of GXM mole-
cules of various sizes (Mcfadden et al., 2006; Frases et al., 2009)
support the hypothesis that variation in these structures could
translate into different biological effects. In fact, Fonseca et al.
(2010) recently established a parallel between the functions of
GXM fractions and their dimensions. Through the use of an
experimental model that included tests of the activation of cellu-
lar responses resulting in nitric oxide production by phagocytes
and activation of Toll-like receptors in epithelial cells, it was
observed that GXM samples isolated from C. gattii (serotype B)
with monosaccharide compositions that were similar to other
polysaccharide fractions produced by C. neoformans (serotypes
A and D) and even by other strains of C. gattii (serotype C)
generated very distinct cellular responses. Measurements of poly-
saccharide diameter by dynamic light scattering (for details about
the technique, see Frases et al., this issue) revealed that the
increased capacity of C. gattii GXM to induce cellular responses
was correlated with a reduced molecular diameter (Fonseca et al.,
2010). These results led to the conclusion that serotype B GXM
samples with reduced dimensions have greater immunobiologi-
cal potential, as demonstrated for chitin (Da Silva et al., 2008,
2009; Lee et al., 2008). It remains unknown, however, whether
this concept would be pertinent to other GXM-producing species,
including members of the Trichosporon genus (Fonseca et al.,
2009).
The ﬁndings discussed above imply new concepts about the
structure and function of fungal polysaccharides. Besides struc-
tural aspects traditionally studied, such as sequence analysis,
compositional determination, anomeric conﬁguration, type of
glycosidic linkage type, and presence of substituents, it becomes
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clear that other structural parameters, including molecular diam-
eter and degree of polymerization, must be considered for func-
tional studies. In fact, the conclusion that polysaccharide functions
are inﬂuenced by these additional parameters was further sup-
ported by Cordero et al. (2011). Using static and dynamic light
scattering, viscosity analysis, and high-resolutionmicroscopy of C.
neoformans polysaccharides, this study demonstrated that spatial
conformation (branching) inﬂuences phagocytosis, nitric oxide
production by macrophage-like cells, and susceptibility to reactive
oxygen species, serology, and clearance during infection. These
previously unexplored parameters can generate new insights, for
example, on immunogenicity assays of polysaccharides, as well as
their use in therapy or prevention of diseases. Studies in this area
are still embryonic and, clearly,much remains to be discovered. For
conceptual validation, future studies must include evaluation of
the relationship between immunoactivity and molecular dimen-
sions of polysaccharides synthesized by other organisms, as well as
of fungal glycans other than GXM and chitin.
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